Status In progress
Technology type Medicine
Decision Selected
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
Further information Topic in appraisal
Process STA Standard
ID number 6439

Provisional Schedule

Committee meeting: 1 04 June 2025
Expected publication 13 August 2025

Project Team

Project lead Jeremy Powell

Email enquiries

External Assessment Group School of Health and Related Research (ScHARR), University of Sheffield

Stakeholders

Companies sponsors Astra Zeneca
Others Department of Health and Social Care
  NHS England
Patient carer groups Kidney Care UK
  Kidney Research UK
  Muslim Council of Great Britain
  National Kidney Federation
  Pumping Marvellous Foundation
  South Asian Health Foundation
  Specialised Healthcare Alliance
Professional groups Association of Renal Technologists
  British Association of Endocrine and Thyroid Surgeons
  British Cardiovascular Society
  British Geriatrics Society
  British Renal Society
  British Society for Heart Failure
  National Metabolic Biochemistry Network
  Renal Association
  Royal College of General Practitioners
  Royal College of Nursing
  Royal College of Pathologists
  Royal College of Physicians
  Royal Pharmaceutical Society
  Royal Society of Medicine
  Society for Endocrinology
  UK Clinical Pharmacy Association
  UK Renal Pharmacy Group
Associated public health groups Public Health Wales
  UK Health Security Agency
Comparator companies none
General commentators All Wales Therapeutics and Toxicology Centre
  Allied Health Professionals Federation
  Board of Community Health Councils in Wales
  British National Formulary
  Care Quality Commission
  Department of Health - Northern Ireland
  Healthcare Improvement Scotland
  Medicines and Healthcare products Regulatory Agency
  National Association of Primary Care
  National Pharmacy Association
  NHS Confederation
  Scottish Medicines Consortium
  Welsh Government
  Welsh Health Specialised Services Committee
Relevant research groups Cochrane Metabolic & Endocrine Disorders Group
  Genomics England
  MRC Clinical Trials Unit
  National Institute for Health Research

Timeline

Key events during the development of the guidance:

Date Update
25 October 2024 Invitation to participate
25 October 2024 In progress. Final scope issued.
28 August 2024 - 11 September 2024 Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators
31 May 2024 Awaiting development

For further information on our processes and methods, please see our CHTE processes and methods manual